Abnormal Biomarkers of Homocysteine Metabolism in Neonates with Conotruncal Heart Defects.

Elevated homocysteine levels in neonates with CHD and folate metabolism disturbances in their mothers were noticed. The observed differences in homocysteine and cobalamin levels between neonates with CHD suggest the influence of various agents disturbing homocysteine metabolic pathways.